Aditi Mehta Becomes Managing Principal at Analysis Group, Elevating Antitrust Practice Aditi Mehta, an esteemed antitrust economist, joins Analysis Group, enhancing their competition policy expertise and broadening regulatory capabilities.

Aditi Mehta Becomes Managing Principal at Analysis Group, Elevating Antitrust Practice #USA #Boston #Analysis_Group #Antitrust_Economics #Aditi_Mehta

Advancements in Health Economics and Outcomes Research for Gene Therapies in Rare Diseases This article explores how health economics and outcomes research is reshaping the evaluation of cell and gene therapies for rare diseases, enhancing accessibility and patient outcomes.

Advancements in Health Economics and Outcomes Research for Gene Therapies in Rare Diseases #United_States #Boston #gene_therapy #Analysis_Group #health_economics

Analysis Group Develops New Framework for Evaluating Multi-Indication Therapies in Healthcare Analysis Group reveals a groundbreaking framework to assess the comprehensive value of therapies across multiple medical indications, enhancing patient access and care.

Analysis Group Develops New Framework for Evaluating Multi-Indication Therapies in Healthcare #USA #Boston #Analysis_Group #Advanced_Therapies #Multi-Indication

Pierre Cremieux Steps Up as the New CEO of Analysis Group Effective January 2025 Analysis Group officially names Pierre Cremieux as its new CEO, taking over from Martha Samuelson, who remains Chairman. Explore this leadership transition.

Pierre Cremieux Steps Up as the New CEO of Analysis Group Effective January 2025 #USA #Boston #Analysis_Group #Pierre_Cremieux #Martha_Samuelson